AB
CVS icon

AT Bancorp’s CVS Health CVS Stock Holding History

AT Bancorp’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.4M Buy
44,590
+10,850
+32% +$670K 0.29% 34
2018
Q4 		$2.21M Buy
33,740
+10,074
+43% +$752K 0.29% 42
2018
Q3 		$1.86M Buy
23,666
+4,627
+24% +$331K 0.2% 67
2018
Q2 		$1.23M Buy
19,039
+10,715
+129% +$706K 0.14% 91
2018
Q1 		$518K Sell
8,324
-795
-9% -$57K 0.06% 162
2017
Q4 		$661K Sell
9,119
-13,440
-60% -$977K 0.07% 135
2017
Q3 		$1.83M Sell
22,559
-908
-4% -$71.8K 0.21% 60
2017
Q2 		$1.89M Sell
23,467
-334
-1% -$26.4K 0.22% 55
2017
Q1 		$1.87M Sell
23,801
-33,147
-58% -$2.65M 0.24% 72
2016
Q4 		$4.49M Sell
56,948
-24,915
-30% -$2.02M 0.6% 24
2016
Q3 		$7.28M Buy
81,863
+8,117
+11% +$766K 1% 17
2016
Q2 		$7.06M Sell
73,746
-5,662
-7% -$564K 1.05% 20
2016
Q1 		$8.24M Buy
79,408
+20,093
+34% +$1.95M 1.24% 14
2015
Q4 		$5.8M Buy
59,315
+23,190
+64% +$2.27M 1.6% 11
2015
Q3 		$3.48M Buy
36,125
+1,233
+4% +$130K 1.01% 26
2015
Q2 		$3.66M Buy
34,892
+2,892
+9% +$295K 0.94% 32
2015
Q1 		$3.3M Buy
32,000
+1,690
+6% +$171K 0.92% 32
2014
Q4 		$2.92M Sell
30,310
-6,909
-19% -$609K 0.87% 40
2014
Q3 		$2.96M Sell
37,219
-21,123
-36% -$1.67M 0.87% 43
2014
Q2 		$4.4M Buy
58,342
+2,899
+5% +$219K 1.32% 20
2014
Q1 		$4.15M Sell
55,443
-10,924
-16% -$772K 1.28% 17
2013
Q4 		$4.75M Buy
66,367
+4,818
+8% +$310K 1.46% 21
2013
Q3 		$3.49M Buy
61,549
+27,580
+81% +$1.64M 1.24% 23
2013
Q2 		$1.94M Buy
+33,969
New +$1.97M 0.7% 55

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AT Bancorp's CVS Position: Q1 2019 in Review

AT Bancorp increased its CVS Health (CVS) stake by 32% in Q1 2019, buying an estimated $670K and bringing the position to 44,590 shares worth $2.4M. The position accounts for 0.29% of the portfolio, ranked #34.

AT Bancorp first reported a position in CVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $8.24M in Q1 2016. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • AT Bancorp held 44,590 shares of CVS Health worth $2.4M as of Q1 2019.
  • AT Bancorp bought 10,850 CVS Health shares in Q1 2019, an estimated $670K.
  • CVS Health made up 0.29% of AT Bancorp's portfolio in Q1 2019, its #34 holding.
  • AT Bancorp first reported a position in CVS Health in Q2 2013 and has held it in 24 quarters since.
  • AT Bancorp's CVS Health position peaked at $8.24M in Q1 2016.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.